SCHEMBL14839477

SCHEMBL14839477

COCCOCCOCCOCCN(C(C)=O)C1CCN(Cc2ccc(-c3cc4nccc(Oc5ccc(NC(=O)NC6CC6)cc5F)c4s3)nc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MST1R Q04912 19/20 0.54
▸ MET P08581 2/20 0.52
▸ AXL P30530 2/20 0.52
▸ KDR P35968 2/20 0.52
▸ FLT3 P36888 2/20 0.52
▸ NTRK1 P04629 1/20 0.52
▸ KIT P10721 1/20 0.52
▸ NTRK2 Q16620 1/20 0.52
▸ PLK4 O00444 1/20 0.49
▸ MAP4K4 O95819 1/20 0.49
▸ ABL1 P00519 1/20 0.49
▸ LCK P06239 1/20 0.49
▸ FYN P06241 1/20 0.49
▸ LYN P07948 1/20 0.49
▸ HCK P08631 1/20 0.49
▸ PDGFRB P09619 1/20 0.49
▸ BCR P11274 1/20 0.49
▸ SRC P12931 1/20 0.49
▸ ABL2 P42684 1/20 0.49
▸ FRK P42685 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14873233 0.94 MST1R (0.53) MST1RMETAXLKDRFLT3
SCHEMBL14873211 0.94 MST1R (0.54) MST1RMETAXLKDRFLT3
SCHEMBL14873235 0.93 MST1R (0.53) MST1RMETAXLKDRFLT3
SCHEMBL16281029 0.93 MST1R (0.55) MST1RMETAXLKDRFLT3
SCHEMBL14873201 0.91 MST1R (0.54) MST1RMETAXLKDRFLT3
SCHEMBL14873310 0.91 MET (0.52) MST1RMETAXLKDRFLT3
SCHEMBL16176981 0.90 MST1R (0.57) MST1RMETAXLKDRFLT3
SCHEMBL14873194 0.90 MST1R (0.57) MST1RMETAXLKDRFLT3
SCHEMBL14873203 0.89 MST1R (0.56) MST1RMETAXLKDRFLT3
SCHEMBL12251159 0.89 MST1R (0.56) MST1RMETAXLKDRFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130096088-A1 Inhibitors of Protein Tyrosine Kinase Activity METHYLGENE INC. (CA) 2013-04-18 — — US disclosed
WO-2013044361-A1 INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY METHYLGENE INC. (CA) 2013-04-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096088-A1 Inhibitors of Protein Tyrosine Kinase Activity KDR, FLT1, FLT4 MST1R 42/4885MET 25/4885AXL 258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback